For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260511:nRSK7301Da&default-theme=true
RNS Number : 7301D Prosus NV 11 May 2026
Prosus N.V.
(Incorporated in the Netherlands)
(Legal Entity Identifier: 635400Z5LQ5F9OLVT688)
AEX and JSE Share Code: PRX ISIN: NL0013654783
(Prosus)
Prosus sells 5% interest in Delivery Hero to Aspex Management
Transaction represents a c.22% premium to the 30-day VWAP
and advances Prosus' commitments made to the European Commission
Transaction summary
· Prosus N.V. (Prosus) has agreed to sell 15,188,284 ordinary
shares in Delivery Hero to Aspex Management, representing approximately 5% of
Delivery Hero's issued share capital.
· The sale price is €22.00 per share, representing a c.10%
premium to the closing share price and a c.22% premium to the 30-day
volume-weighted average price (VWAP) of Delivery Hero shares as of 8 May 2026.
· Total gross proceeds to Prosus from the sale are approximately
€335 million.
In August 2025, the European Commission approved Prosus' acquisition of Just
Eat Takeaway.com, subject to commitments by Prosus to significantly reduce its
shareholding in Delivery Hero. Following Prosus' sale of a 4.5% stake in
Delivery Hero to Uber in April 2026, today's transaction represents a further
step towards fulfilling those commitments.
Amsterdam, the Netherlands
11 May 2026
JSE sponsor to Prosus
Investec Bank Limited
Enquiries
Media
Investor Relations
Charlie
Pemberton
Eoin Ryan
Group Communications
Director
Head of Investor Relations
E:charlie.pemberton@prosus.com (mailto:charlie.pemberton@prosus.com)
E:
eoin.ryan@prosus.com
M: +31 615 494 359
Sbu Tshabalala
Head of Communications, South Africa
E: sibusiso.tshabalala@prosus.com
M: +27 81 431 4855
About Prosus
Prosus is the power behind the world's leading lifestyle ecommerce brands,
across Europe, India, and Latin America, unlocking an AI-first world for our 2
billion customers.
The Prosus technology ecosystem spans food delivery, payments, classifieds,
travel, events, and mobility. Our integrated approach enhances user engagement
and creates the foundation for unprecedented AI capabilities through
proprietary data and cross-service intelligence. Through Prosus Ventures, we
invest in companies which inspire and support the Prosus ecosystem. We search
for new opportunities at the leading edge of AI and ecommerce, the digital AI
workforce and in frontier technologies, such as robotics, drones and synbio.
The team actively backs exceptional entrepreneurs who are using technology to
improve people's everyday lives.
To find out more, please visit (https://www.prosus.com/) www.prosus.com
(http://www.prosus.com)
General restrictions
This announcement is for information purposes only and does not constitute an
offer to sell or issue, or the solicitation of an offer to buy or acquire, any
securities of Prosus or Delivery Hero in any jurisdiction.
The distribution of this announcement may, in some countries, be restricted by
law or regulation. Persons who come into possession of this announcement
should inform themselves of and observe any such restrictions.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DISFLFSTERIILIR
Copyright 2019 Regulatory News Service, all rights reserved